Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Exploring the Causal Role of Circulating Inflammatory Proteins in Multiple Sclerosis: A Mendelian Randomization Study and Druggability Analysis.
Risk of Peripheral Artery Disease and Venous Thromboembolism in Patients with Neuromyelitis Optic Spectrum Disorder: A Nationwide Population-Based Cohort Study.
Unexpected longevity in myasthenia gravis: a multi-state population-based comparison with multiple sclerosis and the U.S. population.
Structure-preserving Image-quality Enhancement for 3D Synthetic FLAIR Using a 3D U-Net with Content and Style Losses.
Immune reconstitution and tolerance-inducing therapies as promising therapeutic approaches in multiple sclerosis.
Recent advances in MR neuroimaging: toward quantitative and AI-driven brain and spinal cord imaging.
Roles of Metformin and Pioglitazone in Regulating A1-like Astrocyte Activation in EAE Mice.
Chronic optic neuropathy: correlating MR imaging features and etiology.
Associations of chrononutrition and sleep with fatigue in multiple sclerosis: an analysis of the Swiss Multiple Sclerosis Registry.
Diabetic Peripheral Neuropathy: Mechanisms and Emerging Therapies.
Endothelial cell-secreted SPARC suppresses astrocytic CD59 expression and promotes astrocytopathy in a mouse model of neuromyelitis optica spectrum disorders.
New Perspectives on oligodendrocytes: Guardians of iron homeostasis and defenders against ferroptosis.
Occurrence of neuronal dysfunction in mice with virus- or toxic-induced lesions in the central nervous system.
Environmental enrichment modulates chronic poststroke inflammation and links white matter TREM2-positive microglia in recovery in mice.
Luteolin as a dietary flavonoid for brain health: modulating neuroinflammation and cognitive decline in neurodegenerative disorders.
Functional food literacy competencies of people with Parkinson's disease and multiple sclerosis: a qualitative study.
Diaphragm hypertrophy and spinal stress response accompany phrenic myelin defects in a murine model of Charcot-Marie-Tooth Disease Type 1E.
Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.
Corrigendum to "Clinical and cognitive outcomes in Ocrelizumab-treated MS patients: Insights into the wearing-off phenomenon" [Multiple Sclerosis and Related Disorders, Volume 103, November 2025, 106689].
The Multiple Sclerosis Drug Fingolimod Induces Pore-Like Membrane Defects, Contributing to Its Antimicrobial Activity.
Affective reserve in older adults with and without multiple sclerosis: A residual-based approach.
Immune therapy engineered inside the body eases multiple sclerosis.
What the 'negative space' tells us about the immunology of multiple sclerosis.
Motor tract lesion mapping from the brain to the lower spinal cord in people with relapsing-remitting multiple sclerosis: exploring the association between lesion severity and functional consequences by limb.
Increased functional network connectivity following cognitive rehabilitation in progressive multiple sclerosis with moderate to severe disabilty: findings from the CogEx study.

Pages